Federal regulators recommended that makers of the two most common drugs used to treat and prevent flu should add warnings that they may cause psychiatric side effects.
F.D.A. Panel Rejects Over-the-Counter Cholesterol Drug
Government advisers rejected on Thursday Mercks bid for over-the-counter sales of Mevacor, the cholesterol-lowering drug. Too many people would mistakenly use the drug if it no longer required a prescription, advisers to the Food and Drug Administration concluded in a 10-to-2 vote against the nonprescription sales.
FDA News